Why the study?
Is a higher cardiometabolic index associated with an increased risk of incident stroke and cerebrovascular mortality in European and American cohorts?
Population
454,293 individuals from the UK Biobank (n=413,686) and NHANES (n=40,607) cohorts
Comparison
Higher cardiometabolic index (CMI) vs Lower cardiometabolic index (CMI)
Design
Cohort
Key result
Each unit increase in the cardiometabolic index was associated with a 24% higher risk of ischemic stroke (HR 1.24; 95% CI 1.21-1.28) and an 11% increased risk of cerebrovascular mortality.
Authors
Loading...
CMI may refine stroke risk assessment in large cohorts; extends prior associations but remains hypothesis-generating without prospective validation.
Cohort (n=454,293)
Yes
Is a higher cardiometabolic index associated with an increased risk of incident stroke and cerebrovascular mortality in European and American cohorts?
Hazard Ratio: 1.24 (95% CI 1.21–1.28)
The cardiometabolic index is a significant, non-linear predictor of incident ischemic stroke and cerebrovascular mortality in large European and American cohorts.
Wang et al. (2026) conducted a cohort in Stroke (n=454,293). Cardiometabolic index (CMI) was evaluated on Incident ischemic stroke (HR 1.24, 95% CI 1.21-1.28). Each unit increase in the cardiometabolic index was associated with a 24% higher risk of ischemic stroke (HR 1.24; 95% CI 1.21-1.28) and an 11% increased risk of cerebrovascular mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: